Compound ID | 1226

Update compound information

OPS-2071

Class: Quinolone

Spectrum of activity: Gram-positive
Details of activity: C. difficile infection
Institute where first reported: Otsuka Pharmaceutical Co. Ltd.
Highest developmental phase: Phase 2
Development status: Active
Chemical structure(s):
Click here for structure editor
Molecular weight: 378.36
Iso. SMILES: CC1=C2C(=CC(=C1C3=CC(=C(N=C3)N)C#N)F)C(=O)C(=CN2C4CC4)C(=O)O
InChI Key: DTSKYQBTFHFYAZ-UHFFFAOYSA-N
Can. SMILES: CC1=C2C(=CC(=C1C3=CC(=C(N)N=C3)C#N)F)C(=O)C(=CN2C4CC4)C(=O)O
InChI: InChI=1S/C20H15FN4O3/c1-9-16(11-4-10(6-22)19(23)24-7-11)15(21)5-13-17(9)25(12-2-3-12)8-14(18(13)26)20(27)28/h4-5,7-8,12H,2-3H2,1H3,(H2,23,24)(H,27,28)
External links:
PubChem link: https://pubchem.ncbi.nlm.nih.gov/compound/71289877
Guide to Pharmacology: OPS-2071
Citations:
  • https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5336415/

  • AntibioticDB is supported by GARDP.

    If you have feedback, experience problems, or are interested in a collaboration, please contact us. | Terms and conditions

    The content of this site is intended for educational and scientific research purposes only and not as a source of medical advice or consultation.